All Type of News


Kolon Life Science signs ‘INVOSSA’ export agreement to Saudi Arabia and UAE

Kolon Life Science(CEO Woo-Seok Lee) signed an exclusive sales & export agreement with Mundipharma as a strategic partner to enter Saudi Arabia and the United Arab Emirates(UAE) with ‘INVOSSA®-K,’ the first knee osteo...

iNtRON Biotechnology acquire U.S. FDA’s Orphan Drug Designation for Endolysin

iNtRON Biotechnology(CEO Kyung-Won Yoon), a new biologic developing company, announced on the 26th that its currently-developing bacillus anthracis based on endolysin called ‘N-Rephasin BAL200(hereinafter referring to...

2 of 5 listed pharmas are managed by multiple CEOs

2 of 5 listed pharmaceutical companies were reportedly managed by more than 2 CEOs. It seems the system spreads for the intent of responsibly running a company with separated roles between shareholders and profession...

Merck to focus on cancer immunotherapy, multiple sclerosis and infertility

Merck Korea, a Korean branch of Merch, the global life science company, announced a promise to lead the future industry by focusing on ‘cancer immunotherapy,’ ‘multiple sclerosis’ and ‘infertility’ in the pharmaceutic...

‘Excellent Bio IP Project’ invested with KRW 827.8 billion for next 10 years

The Excellent Bio Intellectual Property project will get on preliminary validity evaluation after getting ready with strengthened supports. The Ministry of Trade Industry and Energy(Minister Woon-Gyu Baek, MOTIE) and...

Celltrion Healthcare sells Remsima exclusively in Libya and Tunisia

As winning the bidding competition for infliximab biosimilar in the Middle Eastern countries, Celltrion Healthcare started to exclusively sell ‘Remsima(generic name: infliximab),’ a biosimilar for the treatment of aut...

Bukwang acquires the new international occupational healthy and safety standards as pharma

Bukwang Pharm(CEO Hee-Won Yoo) announced to acquire ‘ISO45001,’ the occupational health and safety standards. Newly created by the International Organization for Standardization this March, ISO45001 is a new set of s...

Government to recommend indication of adverse drug reaction damage relief program in containers

It will be recommended to state an instruction about the Adverse Drug Reaction Damage Relief Program in drug containers, packages and documents attached. The Ministry of Food and Drug Safety(MFDS) gave a notice about...

Government, pharma & distribution industries run ‘RFID Technology Support Group’

Recently, the Ministry of Health and Welfare has attracted attention of the people as forming the ‘RFID Technology Support Group’ with the pharmaceutical and distribution industries taking activities. The Ministry of...

“Samsung Biologics might become touchstone for financial reform”

It was argued that Samsung Biologics with accounting fraud and IPO legitimacy issues might become the ‘touchstone for financial reform.’ Won-Gu Ahn, former Director of the Daegu Regional Tax Service, expressed overal...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.